US Patent 7109233 Protease inhibitors
Patent 7109233 was granted and assigned to Smithkline Beecham Limited on September, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+138 characters)
Article
Patent abstract
This invention relates in general to certain substituted substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamides of formula I
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07109233 Protease inhibitors US Patent 7109233 Protease inhibitors
Infobox
Patent Number
0710923300
Patent Number
710923300
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071092330
Date of Patent
September 19, 2006
0Patent Application Number
105151180
Date Filed
May 21, 2003
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071092330
Date of Patent
September 19, 2006
0Patent Application Number
105151180
Date Filed
May 21, 2003
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 17 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07109233 Protease inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07109233
Date of patent
September 19, 2006
Patent application number
10515118
Date Filed
May 21, 2003
Patent primary examiner
Find more entities like US Patent 7109233 Protease inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
